{"id":"W2800924304","doi":"10.1212/wnl.0000000000005347","title":"Practice guideline recommendations summary: Disease-modifying therapies for adults with multiple sclerosis","year":2018,"lang":"en","type":"article","venue":"Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":587,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Manitoba","funders":"MedDay Pharmaceuticals","keywords":"Natalizumab; Medicine; Fingolimod; Guideline; Rituximab; Multiple sclerosis; Progressive multifocal leukoencephalopathy; Systematic review; MEDLINE; Neurology; Intensive care medicine; Family medicine; Psychiatry; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003759168,0.0001955989,0.0003042464,0.0001410973,0.000385087,0.00002437961,0.0001413896,0.00007255279,0.000118352],"category_scores_gemma":[0.003935165,0.000147933,0.0000775017,0.0002080144,0.0003657664,0.0001775492,0.0001097209,0.0002373532,0.00003579856],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002675297,"about_ca_system_score_gemma":0.0001050159,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000194333,"about_ca_topic_score_gemma":0.0004639805,"domain_scores_codex":[0.9982429,0.0001691345,0.0003300193,0.0005065947,0.0002636507,0.0004877753],"domain_scores_gemma":[0.9967034,0.001495542,0.0001356926,0.000463135,0.0009804084,0.0002217537],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.1501817,0.002473401,0.1243477,0.0004637231,0.001577111,0.00006810745,0.005334344,0.00004378706,0.01891973,0.0004552056,0.4749591,0.2211761],"study_design_scores_gemma":[0.009246361,0.006454591,0.09727494,0.0001394808,0.000201592,0.00002584511,0.0003575994,0.008896388,0.0004224344,0.00004374372,0.8766966,0.000240442],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"empirical","genre_scores_codex":[0.464878,0.00127995,0.01125806,0.5133471,0.0007925291,0.004773832,0.0003801885,0.0004977577,0.002792514],"genre_scores_gemma":[0.9524993,0.001226041,0.02710584,0.01746421,0.0008036771,0.0005520222,0.0001624107,0.00006134431,0.0001251413],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.495883,"threshold_uncertainty_score":0.6032534,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0897258710573005,"score_gpt":0.3628580290425424,"score_spread":0.2731321579852419,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}